✦ LIBER ✦

BAFF, a New Target for Intravenous Immunoglobulin in Autoimmunity and Cancer

✍ Scribed by Laëtitia Le pottier; Boutahar Bendaoud; Maryvonne Dueymes; Capucine Daridon; Pierre Youinou; Yehuda Shoenfeld; Jacques-olivier Pers

Publisher: Springer
Year: 2007
Tongue: English
Weight: 419 KB
Volume: 27
Category: Article
ISSN: 0271-9142
DOI: 10.1007/s10875-007-9082-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A new concept for the effector mechanism

A new concept for the effector mechanism of intravenous immunoglobulin in hemocytopenias

✍ Mueller-Eckhardt, C. ;Salama, A. ;Kiefel, V. ;K�enzlen, E. ;F�rster, C. 📂 Article 📅 1984 🏛 Springer-Verlag ⚖ 259 KB

Immunoglobulin-binding proteins in ticks

Immunoglobulin-binding proteins in ticks: new target for vaccine development against a blood-feeding parasite

✍ H. Wang; P. A. Nuttall 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 272 KB

Cancer stem cells in prostate adenocarci

Cancer stem cells in prostate adenocarcinoma: a target for new anticancer strategies

✍ D. Fioriti; M. Mischitelli; F. Di Monaco; F. Di Silverio; E. Petrangeli; G. Russ 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views

## Abstract Prostate cancer (PC) is major common malignancy in males in most industrialized Western countries, where it is the most commonly diagnosed cancer affecting men after middle age (>50 years). Over 90% of PC patients with incurable disease respond to primary treatment, which consists of in

Successful control of refractory and lif

Successful control of refractory and life-threatening autoimmune hemolytic anemia with intravenous immunoglobulins in a man with the primary antiphospholipid syndrome

✍ P. Vandenberghe; P. Zachee; S. Verstraete; H. Demuynck; M. A. Boogaerts; G. E. G 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 152 KB

Vimentin in cancer and its potential as

Vimentin in cancer and its potential as a molecular target for cancer therapy

✍ Arun Satelli; Shulin Li 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 417 KB

Hyperferritinemia as indicator for intra

Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes

✍ Urban Emmenegger; Ursula Frey; Andrea Reimers; Christoph Fux; David Semela; Phil 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

## Abstract The underlying mechanisms of reactive macrophage activation syndromes (rMAS) are not understood in detail, and there is no specific treatment. This observational study was prompted by intravenous immunoglobulin (IVIG), dramatically halting two distinct rMAS episodes in the same patient.